London: The Al Hikma Modern Hospital, Zarqa, Jordan, today announced it is the first hospital in the region to adopt the geko™ device to treat and prevent acute lower limb post-operative and trauma-based oedema for enhanced recovery.
Oedema, the medical term for swelling – a huge and, until now, silent burden with few tools to address the complication – can delay pre-operative surgical fixation, impede post-operative wound closure, decrease muscle strength and stall rehabilitation.
The current standard of care for pre-operative oedema reduction in ankle fracture patients is a backslab plaster cast in combination with leg elevation; and for post-operative elective surgeries, most often a boot-like cuff that compresses the lower limb to increase blood flow, called intermittent pneumatic compression (IPC).
IPC, however, is not suitable for all patients due to vascular disease, fragile skin, or complex limb injury. IPC also requires resource to correctly fit the cuffs and the pneumatic pumps to inflate them are not always readily available – and elevation alone, can cause increased length of hospital stay and with it increased costs. The result is the need for an alternative mechanical intervention that can surpass IPC and leg elevation – a therapy able to reduce length of hospital stay, follow a patient home, facilitate enhanced recovery and allow rehabilitation to begin sooner.
To address this significant unmet need, the orthopaedic department at the Al Hikma Hospital, led by Dr Sameih Ismail Abu Khaleifa, Consultant Orthopaedic Surgeon, has adopted Sky Medical Technology’s geko™ device. A small watch-sized device that sticks to the side of the knee, increasing blood flow in the deep veins of the calf, via painless electrical pulses, at a rate equal to 60 percent of walking without a patient having to move. Through this mechanism of non-invasive neuromuscular electrostimulation, the device prevents oedema build-up and enables oedema clearance by local reabsorption of oedematous fluid into the vasculature and lymphatic systems,.
Influenced by compelling NHS real-world data, reporting a pre-operative 2 day improvement in readiness for surgery in ankle fracture patients; and an RCT (randomized control trial) demonstrating post-operative oedema prevention in hip replacement patients, Dr Sameih Ismail Abu Khaleifa saw the potential for the innovative geko™ device and embraced the opportunity to examine its role and subsequent adoption into clinical practice.
Dr Sameih Ismail Abu Khaleifa, Consultant Orthopedic Surgeon, said: “Lower limb post-operative and trauma-based oedema is a complicating factor that can impact length of hospital stay, functional recovery and readmission rates1. My team were therefore keen to explore geko™ device use as an alternative mechanical intervention to enhance recovery. The easy-to-use device, the size of a wrist-watch, is now in routine use providing safe and well-tolerated oedema control, ensuring that all of our patients can now receive appropriate oedema management for better clinical outcomes – and importantly improved patient satisfaction.”
Bernard Ross, founder and CEO of Sky Medical Technology, said: “I am delighted that Dr Sameih Ismail Abu Khaleifa and his clinical team are the first in their region to champion use of the geko™ device to manage post-operative and trauma-based oedema, essential to optimizing the effectiveness of other interventions, such as physical therapy, that combined can enhance functional recovery. My thanks also goes to Tadawi Medical Supplies, importer and distributor of the geko™ device, for supporting innovation adoption in orthopaedics at the Al Hikma hospital.”
About the geko™ device
The geko™ is a neuromuscular electrostimulation device that gently stimulates the common peroneal nerve with small electrical pulses, activating the calf and foot muscle pumps to increase blood flow in the deeps veins of the calf at a rate equal to 60% of walking without the patient having to move. In the circumstance of lower limb trauma, the geko™ reduces the net filtration of fluid leakage from the capillary bed. Through this unique mechanism of action, the geko™ device prevents oedema build-up and enables oedema clearance by local reabsorption of excess interstitial fluid into the vasculature and lymphatic systems. Weighing just 10g, silent in operation and with no wires or leads, the battery powered geko™ is a daily disposable device that is self-adhesive and comfortable to wear.
About Firstkind and Sky Medical Technology Ltd
Sky Medical Technology, the parent of Firstkind Ltd, is a UK-based medical devices company. Through its innovative mechanism of neuromuscular electrostimulation, Sky has developed a non-invasive, ground-breaking technology platform, OnPulse™, embedded in its industry-leading brand, the geko™ device. Sky’s products are tailored to different medical application areas, selling through strategic partnerships or distributors in each major clinical area. Clinical areas of focus include life threatening blood clots, complications related to swelling after orthopaedic surgery and vascular conditions related to wound healing. The goal in each pathway is to partner with healthcare professionals to improve clinical outcomes and patient care whilst saving health system resources.
About Tadawi Medical Supplies Est
Tadawi is a leading importer and distributor of medical equipment for the Jordanian market. Focus application areas include intensive care and wound therapy, alongside exclusive distribution agreements with leading international companies in the respiratory field. Their selling organization has a strong medical background, with staff drawn from medical device engineering, nursing and health education.